The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...

Dr. Coleman: For patients with recurrent ovarian cancer, the main benefit of adding Lifyorli to nab-paclitaxel is controlling ...

A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...

That choice was not available to me. My perspective on genetic risk isn't theoretical. My mother, Ioanna, died when I was 9.

Author and survivor Parul Somani shares how patients with breast cancer can find peace of mind when clinical certainty is ...

The study's safety findings suggest that the physical "number" of a patient's age is less important than their functional ...

Christine Fader shares how her husband’s past trauma shaped his cancer treatment experience and why awareness and patient ...

CTIM-76 has received FDA fast track designation for platinum-resistant ovarian cancer, a step aimed at accelerating ...

FDA NDA submission for bezuclastinib targets post-imatinib GIST, using Real-Time Oncology Review and supported by prior ...

U.S. Food and Drug Administration (FDA) has approved a PD-L1 companion diagnostic test for patients with esophageal cancer or ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

A kidney cancer survivor shares how a decade of breakthroughs in immunotherapy and targeted research transformed a death ...